These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


724 related items for PubMed ID: 18405408

  • 1. Levosimendan infusion improves haemodynamics in elderly heart failure patients undergoing urgent hip fracture repair.
    Ponschab M, Hochmair N, Ghazwinian N, Mueller T, Plöchl W.
    Eur J Anaesthesiol; 2008 Aug; 25(8):627-33. PubMed ID: 18405408
    [Abstract] [Full Text] [Related]

  • 2. Prophylactic treatment with levosimendan: a retrospective matched-control study of patients with reduced left ventricular function.
    Kolseth SM, Nordhaug DO, Stenseth R, Sellevold O, Kirkeby-Garstad I, Wahba A.
    Eur J Cardiothorac Surg; 2009 Dec; 36(6):1024-30. PubMed ID: 19592266
    [Abstract] [Full Text] [Related]

  • 3. Levosimendan in patients with low-output heart failure: lessons from the LIDO trial.
    Follath F.
    Ital Heart J; 2003 May; 4 Suppl 2():34S-38S. PubMed ID: 14635368
    [Abstract] [Full Text] [Related]

  • 4. Effect of levosimendan on ventricular arrhythmias and prognostic autonomic indexes in patients with decompensated advanced heart failure secondary to ischemic or dilated cardiomyopathy.
    Flevari P, Parissis JT, Leftheriotis D, Panou F, Kourea K, Kremastinos DT.
    Am J Cardiol; 2006 Dec 15; 98(12):1641-5. PubMed ID: 17145226
    [Abstract] [Full Text] [Related]

  • 5. Levosimedan improves hemodynamics functions without sympathetic activation in severe heart failure patients: direct evidence from sympathetic neural recording.
    Despas F, Trouillet C, Franchitto N, Labrunee M, Galinier M, Senard JM, Pathak A.
    Acute Card Care; 2010 Mar 15; 12(1):25-30. PubMed ID: 19929264
    [Abstract] [Full Text] [Related]

  • 6. Effects of levosimendan versus dobutamine on inflammatory and apoptotic pathways in acutely decompensated chronic heart failure.
    Adamopoulos S, Parissis JT, Iliodromitis EK, Paraskevaidis I, Tsiapras D, Farmakis D, Karatzas D, Gheorghiade M, Filippatos GS, Kremastinos DT.
    Am J Cardiol; 2006 Jul 01; 98(1):102-6. PubMed ID: 16784930
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of perioperative infusion of levosimendan in patients with compromised cardiac function undergoing open-heart surgery: importance of early use.
    Tasouli A, Papadopoulos K, Antoniou T, Kriaras I, Stavridis G, Degiannis D, Geroulanos S.
    Eur J Cardiothorac Surg; 2007 Oct 01; 32(4):629-33. PubMed ID: 17702589
    [Abstract] [Full Text] [Related]

  • 8. Levosimendan reduces plasma B-type natriuretic peptide and interleukin 6, and improves central hemodynamics in severe heart failure patients.
    Kyrzopoulos S, Adamopoulos S, Parissis JT, Rassias J, Kostakis G, Iliodromitis E, Degiannis D, Kremastinos DT.
    Int J Cardiol; 2005 Mar 30; 99(3):409-13. PubMed ID: 15771921
    [Abstract] [Full Text] [Related]

  • 9. Safety and effectiveness of levosimendan in patients with predominant right heart failure.
    Poelzl G, Zwick RH, Grander W, Metzler B, Jonetzko P, Frick M, Ulmer H, Pachinger O, Roithinger FX.
    Herz; 2008 Jul 30; 33(5):368-73. PubMed ID: 18773157
    [Abstract] [Full Text] [Related]

  • 10. Levosimendan improves renal function in patients with advanced chronic heart failure awaiting cardiac transplantation.
    Zemljic G, Bunc M, Yazdanbakhsh AP, Vrtovec B.
    J Card Fail; 2007 Aug 30; 13(6):417-21. PubMed ID: 17675054
    [Abstract] [Full Text] [Related]

  • 11. The effects of levosimendan in cardiac surgery patients with poor left ventricular function.
    De Hert SG, Lorsomradee S, Cromheecke S, Van der Linden PJ.
    Anesth Analg; 2007 Apr 30; 104(4):766-73. PubMed ID: 17377079
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of levosimendan on right ventricular function in patients with advanced heart failure.
    Parissis JT, Paraskevaidis I, Bistola V, Farmakis D, Panou F, Kourea K, Nikolaou M, Filippatos G, Kremastinos D.
    Am J Cardiol; 2006 Dec 01; 98(11):1489-92. PubMed ID: 17126656
    [Abstract] [Full Text] [Related]

  • 14. Levosimendan as a new strategy during off-pump coronary artery bypass grafting: double-blind randomized placebo-controlled trial.
    Husedzinović I, Barisin S, Bradić N, Barisin A, Sonicki Z, Milanović R.
    Croat Med J; 2005 Dec 01; 46(6):950-6. PubMed ID: 16342349
    [Abstract] [Full Text] [Related]

  • 15. Repeated infusions of levosimendan: well tolerated and improves functional capacity in decompensated heart failure - a single-centre experience.
    Parle NM, Thomas MD, Dembo L, Best M, Driscoll GO.
    Heart Lung Circ; 2008 Jun 01; 17(3):206-10. PubMed ID: 18242130
    [Abstract] [Full Text] [Related]

  • 16. The utility of levosimendan in the treatment of heart failure.
    Lehtonen L, Põder P.
    Ann Med; 2007 Jun 01; 39(1):2-17. PubMed ID: 17364447
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effect of levosimendan on estimated glomerular filtration rate in hospitalized patients with decompensated heart failure and renal dysfunction.
    Hou ZQ, Sun ZX, Su CY, Tan H, Zhong X, Hu B, Zhou Y, Shang DY.
    Cardiovasc Ther; 2013 Apr 01; 31(2):108-14. PubMed ID: 23490237
    [Abstract] [Full Text] [Related]

  • 19. The calcium sensitizer levosimendan improves the function of stunned myocardium after percutaneous transluminal coronary angioplasty in acute myocardial ischemia.
    Sonntag S, Sundberg S, Lehtonen LA, Kleber FX.
    J Am Coll Cardiol; 2004 Jun 16; 43(12):2177-82. PubMed ID: 15193677
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 37.